Dear Colleagues: Welcome to the March issue of Innovations in Clinical Neuroscience. Innovation in neuroscience may not always be demonstrated in the creation of a novel drug or technologically advanced
by Ronald Pies, MD; Michael H. Fisher, PhD; and C.V. Haldipur, MD, MRCPsy Dr. Pies is from SUNY Upstate Medical University, Syracuse, New York, and Tufts University School of Medicine,
by Debra L. Safer, md, and Katherine D. Arnow, BA Both from Stanford University School of Medicine, Department of Psychiatry and Behavioral Sciences, Stanford, California Innov Clin Neurosci. 2012;9(3):13–16
by Leslie Citrome, MD, MPH; Zhenchao Guo, PhD; Iftekhar Kalsekar, PhD; Robert A. Forbes, PhD; and Tony Hebden, PhD Dr. Citrome is with the Department of Psychiatry and Behavioral Sciences,
by Surendra Kumar Mattoo, MD; Natasha Kate, MD; and Anant Kumar Verma, MD All from the Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India Innov
by Randy A. Sansone, MD, and Lori A. Sansone, MD Dr. R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of
by Kathryn E. Heagerty, BSN, JD Ms. Heagerty is a Risk Manager for PRMS, Inc. Innov Clin Neurosci. 2012;9(3):27–29
by Peggy Scallon, MD Dr. Scallon is a Clinical Assistant Professor and Residency Training Director in Child and Adolescent Psychiatry at the University of Wisconsin School of Medicine and Public
The Despotic Habit of Gambling
by Assad Meymandi, MD, PhD, DLFAPA Dr. Meymandi is in private practice as a psychiatrist and neurologist and serves as an adjunct professor of psychiatry at the University of North
Read More